Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11839689 Formulations of enzalutamide

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
November 11, 2022
0
Date of Patent
December 12, 2023
0
Patent Application Number
17985235
0
Patent Citations
‌
US Patent 7709517 Diarylhydantoin compounds
0
‌
US Patent 8183274 Treatment of hyperproliferative disorders with diarylhydantoin compounds
0
‌
US Patent 7780988 Method for making homogeneous spray-dried solid amorphous drug dispersions using pressure nozzles
0
‌
US Patent 8445507 Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
0
‌
US Patent 6899899 Rapidly disintegrable pharmaceutical composition
0
‌
US Patent 7189415 Rapidly disintegrable pharmaceutical composition
0
Patent Inventor Names
Toshiro Sakai
0
Koji Nishimura
0
Jason A. Everett
0
Douglas Alan Lorenz
0
Sanjay Konagurthu
0
Hiroyasu Toyota
0
Shinsuke Oba
0
Yuuki Takaishi
0
Randy J. Wald
0
Atsushi Kanbayashi
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11839689
0
Patent Primary Examiner
‌
Carlos A. Azpuru
0
CPC Code
‌
A61K 9/10
0
‌
A61K 9/2054
0

Find more entities like US Patent 11839689 Formulations of enzalutamide

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo